[go: up one dir, main page]

TR200001330T2 - Oksazolidinon türevleri ve farmasötik terkipler - Google Patents

Oksazolidinon türevleri ve farmasötik terkipler

Info

Publication number
TR200001330T2
TR200001330T2 TR2000/01330T TR200001330T TR200001330T2 TR 200001330 T2 TR200001330 T2 TR 200001330T2 TR 2000/01330 T TR2000/01330 T TR 2000/01330T TR 200001330 T TR200001330 T TR 200001330T TR 200001330 T2 TR200001330 T2 TR 200001330T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
oxazolidinone derivatives
organisms
gram
compounds
Prior art date
Application number
TR2000/01330T
Other languages
English (en)
Inventor
B. Hester Jackson Jr.
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of TR200001330T2 publication Critical patent/TR200001330T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formül I e sahip bir bilesik: veya bunun farmasötik açidan kabul edilebilir bir tuzu olup; bu bilesikler, gram pozitif aerobik organizmalar, gram negatif organizmalar ve anaerobik organizmalar dahil, çesitli insan ve hayvan patojenlerine karsi etkili antimikrobiyal maddelerdir.
TR2000/01330T 1997-11-12 1998-10-30 Oksazolidinon türevleri ve farmasötik terkipler TR200001330T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12

Publications (1)

Publication Number Publication Date
TR200001330T2 true TR200001330T2 (tr) 2000-11-21

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01330T TR200001330T2 (tr) 1997-11-12 1998-10-30 Oksazolidinon türevleri ve farmasötik terkipler

Country Status (21)

Country Link
US (1) US5998406A (tr)
EP (1) EP1030852B1 (tr)
JP (1) JP2001522849A (tr)
KR (1) KR20010031953A (tr)
CN (1) CN1154644C (tr)
AT (1) ATE250054T1 (tr)
AU (1) AU739055B2 (tr)
BR (1) BR9813985A (tr)
CA (1) CA2303959A1 (tr)
DE (1) DE69818294T2 (tr)
DK (1) DK1030852T3 (tr)
ES (1) ES2207010T3 (tr)
HU (1) HUP0100470A3 (tr)
IL (1) IL136062A (tr)
NO (1) NO317291B1 (tr)
NZ (1) NZ504503A (tr)
PT (1) PT1030852E (tr)
RU (1) RU2215740C2 (tr)
SK (1) SK284577B6 (tr)
TR (1) TR200001330T2 (tr)
WO (1) WO1999024428A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0413838A (pt) * 2003-08-25 2006-10-24 Warner Lambert Co compostos de ariloxazolidinona antimicrobianos
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008521792A (ja) * 2004-11-29 2008-06-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌薬としてのジアゼピンオキサゾリジノン
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
ATE449773T1 (de) 2005-06-29 2009-12-15 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
WO2009044777A1 (ja) * 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory ７員ヘテロ環を有するオキサゾリジノン誘導体
WO2012059823A1 (en) 2010-11-03 2012-05-10 Wockhardt Limited Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl] - 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
CA1317594C (en) * 1987-10-21 1993-05-11 Chung-Ho Park Aminomethyloxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ATE112773T1 (de) * 1988-09-15 1994-10-15 Upjohn Co 5-indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(nitrogen- substituierte)phenyl-5-beta-amidomethyloxazolid n-2-one.
CA2119556C (en) * 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1271358A (zh) 2000-10-25
SK284577B6 (sk) 2005-07-01
HUP0100470A3 (en) 2002-08-28
EP1030852A1 (en) 2000-08-30
IL136062A0 (en) 2001-05-20
KR20010031953A (ko) 2001-04-16
NO20002434D0 (no) 2000-05-11
ES2207010T3 (es) 2004-05-16
IL136062A (en) 2004-02-08
EP1030852B1 (en) 2003-09-17
BR9813985A (pt) 2000-09-26
NO317291B1 (no) 2004-10-04
RU2215740C2 (ru) 2003-11-10
AU739055B2 (en) 2001-10-04
CN1154644C (zh) 2004-06-23
AU1277899A (en) 1999-05-31
NZ504503A (en) 2002-10-25
WO1999024428A1 (en) 1999-05-20
JP2001522849A (ja) 2001-11-20
HUP0100470A2 (hu) 2002-05-29
SK6182000A3 (en) 2000-12-11
DK1030852T3 (da) 2003-12-22
PT1030852E (pt) 2004-02-27
DE69818294D1 (de) 2003-10-23
DE69818294T2 (de) 2004-07-08
CA2303959A1 (en) 1999-05-20
HK1030373A1 (en) 2001-05-04
NO20002434L (no) 2000-05-11
US5998406A (en) 1999-12-07
ATE250054T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
HUT77602A (hu) Mikrobicid hatású fenil-oxazolidinon-származékok és alkalmazásuk gyógyszerkészítmények előállítására
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
HRP20050516B1 (hr) N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
AR029226A1 (es) Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
DE60123277D1 (de) Makrolidantibiotika
IL139437A0 (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE219085T1 (de) 2-beta-substituierte-6-alkylidenpenizillansäure derivate als beta-laktamase inhibitoren
DK0824539T3 (da) Dialkyltiacumicin-forbindelser
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
ATE165101T1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
DE60005517D1 (de) Kaliumkanal-blockierende mittel
NO993774L (no) Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
DE69812059D1 (de) Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A
TR199902820T2 (tr) Multisiklik eritromisin türevleri.
BR0215070A (pt) Métodos de tratamento de infecções bacterianas em cães e gatos
NO982879L (no) Vannlöselige antibiotika